Insights from Dr. Tashko
Why Graves’ Disease Care Must Be Personalized
Graves’ disease affects more than thyroid hormone levels. Symptoms, eye health, pregnancy plans, and metabolic changes can shape treatment decisions. This article explains how accurate diagnosis, careful medication adjustments, and ongoing follow-up connect with recovery. Discover a personalized approach that considers the whole person, with comprehensive thyroid care in Montgomery County, Maryland, and virtual care for eligible patients beyond the region seeking thoughtful endocrine support.
Published
Why Your Insulin Prescription May Run Out Too Soon
Running out of insulin before your next refill can reveal a mismatch between your prescription and actual needs. Dose changes, pen priming, pump preparation, and product discard dates all affect supply. This article explains how individualized prescription planning and pharmacy coordination help address these gaps for people with type 1 diabetes, with practical guidance for recognizing problems early and seeking timely clinical support when needed.
Published
Why Type 1 Diabetes Care Must Extend Beyond Visits
Type 1 diabetes care continues long after an appointment ends. Insulin access, device support, glucose interpretation, and emergency planning all require thoughtful coordination. This article explains how personalized care connects these needs with heart health, hormonal conditions, and emotional well-being. Discover why ongoing communication and practical follow-through matter for patients in Montgomery County, Maryland, and eligible patients receiving virtual care beyond the local practice area.
Published
After Polyp Removal: Can Your Next Colonoscopy Wait?
Can your next colonoscopy wait after polyp removal? This article reviews a large randomized trial comparing surveillance beginning at three versus five years. Cancer incidence remained similar at five years, but longer follow-up continues. Learn how these findings fit current recommendations and why polyp characteristics, examination quality, and your medical history still guide a personalized plan for colorectal cancer prevention with your gastroenterology care team.
Published
After Kidney Injury, Could Earlier SGLT2 Treatment Help?
A study examined adults with type 2 diabetes who recovered from acute kidney injury severe enough to require dialysis. Starting an SGLT2 inhibitor within 30 days after discharge was associated with fewer kidney events than waiting until days 31–90. The findings suggest that once blood pressure, fluid balance, oral intake, and kidney function stabilize, earlier treatment may offer protection without creating a prolonged therapeutic gap.
Published
Categorized as Diabetes Care, Dr. Tashko’s Key Clinical Trials, Insights from Dr. Tashko, Kidney Health
Heart Failure Is Becoming a Cardiometabolic Disease
The 2026 ESC guideline changes how clinicians classify and treat heart failure. It removes the intermediate HFmrEF category, expands reduced-ejection-fraction heart failure below 50%, and recommends SGLT2 inhibitors and appropriate mineralocorticoid-receptor antagonists across the symptomatic spectrum. The guideline also brings obesity treatment, blood-pressure control, kidney protection, sleep evaluation, exercise, and muscle preservation into one integrated cardiometabolic framework for modern, individualized heart-failure care across diverse patients.
Published
New Study: Hybrid Obesity Care Beyond Weight Loss
A new randomized trial examined whether a 20-week hybrid lifestyle program could improve obesity treatment beyond usual medical care. Although it did not significantly increase the number of participants losing at least 5% of their weight, several cholesterol and liver markers improved. The findings show why obesity care should measure metabolic health, adherence, medication use, and sustainable daily habits alongside changes on the scale alone.
Published
Categorized as Dr. Tashko’s Key Clinical Trials, Insights from Dr. Tashko, Metabolic Care, Obesity Care
Why Lifestyle Programs Lose Power in Real Life
Clinical trials show that lifestyle programs can improve weight and metabolic health, yet results often weaken in everyday care. The problem is not simply motivation. Biological adaptation, demanding schedules, transportation, digital access, caregiving, and fragmented follow-up all shape participation. This blog explains why effective treatment must fit the patient’s physiology, responsibilities, resources, and capacity if meaningful progress is expected to last over the long term.
Published
Rethinking BMI: A Practical Way to Diagnose Obesity
Obesity diagnosis should begin with BMI, but it should not end there. Waist measurements reveal central adiposity, while organ health and daily function show whether excess body fat has become an active disease. This practical four-step framework connects body size, physiology, function, and treatment intensity. It also identifies hidden risks early, such as sarcopenic obesity, weight-promoting medications, sleep apnea, fatty liver disease, and declining mobility.
Published
Why a Lower HbA1c Is Not Always Better After 65
A lower HbA1c can look reassuring, but in older adults it may hide recurrent hypoglycemia, unstable glucose, or excessive treatment. Individualized targets consider health, kidney function, cognition, nutrition, medications, and daily independence. This article explains why Time in Range matters, when insulin or sulfonylureas deserve reassessment, and how safer diabetes care balances long-term protection with immediate quality of life and preserves confidence in daily living.
Published
Categorized as Diabetes Care, Endocrine Health in Older Adults, Insights from Dr. Tashko, Metabolic Care
Beyond BMI: What a New Obesity Study Reveals
A new JAMA Network Open study asks whether obesity diagnosis needs several body measurements or whether BMI and waist circumference can provide enough practical information. The results show that BMI alone misses many people with excess body fat, while waist measurement adds meaningful insight. However, no number can replace a broader evaluation of metabolic health, organ function, muscle health, sleep, and daily function over time.
Published
Categorized as Dr. Tashko’s Key Clinical Trials, Insights from Dr. Tashko, Metabolic Care, Obesity Care
Structured Transcendence in Clinical Endocrinology and Metabolism
Modern endocrinology can measure glucose, cholesterol, thyroid function, blood pressure, inflammation, hormones, and body composition with remarkable precision. Yet metabolism does not operate as isolated numbers. This essay explores structured transcendence, the higher-order coherence that emerges when endocrine signals, circadian rhythms, skeletal muscle, sleep, inflammation, and adaptation work together. True metabolic health depends not on perfect values, but on resilient, harmonious physiological coordination over time.
Published